Navigation Links
Researchers discover that same gene has opposite effects in prostate, breast cancers
Date:10/16/2011

Researchers at Cleveland Clinic have discovered that a gene known as an androgen receptor (AR) is found in both prostate and breast cancers yet has opposite effects on these diseases.

In prostate cancer, the AR gene promotes cancer growth when the gene is "turned on." In breast cancer, the AR gene promotes cancer growth when the gene is "turned off," as is often the case after menopause, when AR production ceases in women.

What this means is that treating prostate and breast cancers require completely opposite approaches to AR. In treating prostate cancer, the strategy should be to block AR; in breast cancer, the strategy should be to support AR production.

Researchers from Cleveland Clinic's Lerner Research Institute, including Charis Eng, M.D., Ph.D., Chair, Genomic Medicine Institute; Robert Silverman, Ph.D., and Warren Heston, Ph.D., both of the Department of Cancer Biology; focused on whether the androgen receptor (AR) molecule offers evidence of the tumor suppressor protein PTEN. The research discovered that AR inhibits PTEN expression in prostate cancer cells, but stimulates it in breast cancer cells.

The conclusions, published in the Oct. 21, 2011 issue of Oncogene, explain why prostate cancer progression is associated with increased AR expression (and a common prostate cancer treatment strategy involves blocking AR), while most breast cancers occur post-menopause, after AR production has ceased (making AR supplementation a strategy for treating breast cancer).

Dr. Eng and her colleagues have mapped the interaction between AR and PTEN in both prostate and breast cancer cells, which suggests that this interaction activates or represses subsequent gene expression depending on organ-specific cofactors. Although PTEN is a known tumor suppressor, and loss of PTEN expression has been associated with numerous cancers (including breast and prostate cancers), its regulation has not been well understood. The current data provide new information regarding PTEN regulation, and suggest that identifying regulatory cofactors will be a valuable next step in determining cancer risk, as well as potential new therapies.

"We now see how androgen affects PTEN expression and ultimately cancer," said Dr. Eng. "Our observations help explain why this prostate cancer risk can be halved by drinking red wine, which increases PTEN expression. Our data also suggest that treatment of the exact same cancer must be personalized for males and for females."


'/>"/>
Contact: Dan Doron
dorond@ccf.org
216-312-0428
Cleveland Clinic
Source:Eurekalert

Related biology news :

1. Researchers do precise gene therapy without a needle
2. Researchers explore planktons shifting role in deep sea carbon storage
3. Stanford researchers examine impact of green politics on recent national elections
4. NIH grant will allow researchers to look for viral cause of most severe form of multiple sclerosis
5. UNH researchers receive NSF grant to scale up stream ecology
6. Medical College of Wisconsin researchers show molecule inhibits metastasis
7. Researchers study agings effect on the brain
8. Notre Dame researchers report progress on compound to treat neurological diseases
9. UNH researchers: Multibeam sonar can map undersea gas seeps
10. Researchers realize high-power, narrowband terahertz source at room temperature
11. Researchers: Apply public trust doctrine to rescue wildlife from politics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2017)... Va. , June 30, 2017 ... leading developer and supplier of face and eye ... ATA Featured Product provider program. ... an innovative way to monitor a driver,s attentiveness ... greatly from being able to detect fatigue and ...
(Date:5/16/2017)...  Veratad Technologies, LLC ( www.veratad.com ), an innovative ... verification solutions, announced today they will participate as a ... thru May 17, 2017, in Washington D.C.,s ... Identity impacts the lives of billions ... evolving digital world, defining identity is critical to nearly ...
(Date:4/19/2017)... The global military biometrics market ... by the presence of several large global players. The ... major players - 3M Cogent, NEC Corporation, M2SYS Technology, ... 61% of the global military biometric market in 2016. ... military biometrics market boast global presence, which has catapulted ...
Breaking Biology News(10 mins):
(Date:9/26/2017)... ... 2017 , ... arivis, Inc., a provider of clinical and ... Shield EU-US. This milestone assures clients using arivis Clireo technologies that their data ... arivis clients can more assuredly operate their clinical and regulatory processes within Clireo, ...
(Date:9/25/2017)... ... September 25, 2017 , ... Throughout the month of ... Verified label at over 13,000 stores nationwide, and industry expert David Carter is available ... that Congress has passed the GMO labeling bill, demand for non-GMO foods and beverages ...
(Date:9/25/2017)... Jordan, UT, and Portland, OR (PRWEB) , ... ... ... CallTower , an industry-leading Unified Communications (UC) and Collaboration company, ... performance in real-time, announced today a strategic alliance to extend CallTower’s Unified ...
(Date:9/22/2017)... ... 2017 , ... Brain State Technologies®, a leading neurotechnology company, ... be used to fund production of the company’s new B2v2® brainwave balancing headband. ... 1,000%. , The B2v2 is the world’s first brain-mirroring wellness product for home ...
Breaking Biology Technology: